These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22850945)

  • 1. An evaluation of p16(INK4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1.
    Nicol AF; Golub JE; e Silva JR; Cunha CB; Amaro-Filho SM; Oliveira NS; Menezes W; Andrade CV; Russomano F; Tristão A; Grinsztejn B; Friedman RK; Oliveira MP; Pires A; Nuovo GJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):571-7. PubMed ID: 22850945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
    Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
    BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R; Li X; Qian M; Niu J; You Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
    Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
    Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 6. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
    Gurrola-Díaz CM; Suárez-Rincón AE; Vázquez-Camacho G; Buonocunto-Vázquez G; Rosales-Quintana S; Wentzensen N; von Knebel Doeberitz M
    Gynecol Oncol; 2008 Oct; 111(1):120-4. PubMed ID: 18692882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
    Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
    Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization.
    Cardoso FA; Campaner AB; Silva MA
    APMIS; 2014 Mar; 122(3):192-9. PubMed ID: 23763281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia.
    Pacchiarotti A; Galeotti S; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Am J Clin Pathol; 2014 Mar; 141(3):367-73. PubMed ID: 24515764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions.
    Queiroz C; Silva TC; Alves VA; Villa LL; Costa MC; Travassos AG; Filho JB; Studart E; Cheto T; de Freitas LA
    Pathol Res Pract; 2006; 202(2):77-83. PubMed ID: 16376485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
    Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
    Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
    Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
    Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
    Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.